194 web-programmer-developer-university-of-liverpool Postdoctoral research jobs at University of Oxford
Sort by
Refine Your Search
-
Listed
-
Field
-
. Successful applicants will work closely with our national and international collaborators and are expected to develop innovative research approaches. The role also includes the possibility to co-advice
-
on transplant using multimodal medical data. You will be responsible for literature review, data cleaning, model development and implementation. You should possess a relevant PhD (or near completion) in
-
to reveal cells, genes, proteins and pathways underlying the infection process, parasite development and interaction with the hosts. These findings are further validated by in situ localization of gene
-
semiconductors for renewable energy generation”. This collaborative project will tackle the complex array of exciting fundamental science arising in “soft” inorganic and hybrid semiconductors, seeking to develop
-
the Nuffield Department of Medicine, University of Oxford. GlaxoSmithKline and Oxford University (GO) launched the PRECISE Alliance (Pre-Cancer Biology and Immunoprevention) in 2024, with the aim of conducting
-
team based at the Nuffield Department of Medicine, University of Oxford. GlaxoSmithKline and Oxford University (GO) launched the PRECISE Alliance (Pre-Cancer Biology and Immunoprevention) in 2024, with
-
replication. This post is fixed term for 3 years. What are you going to do? In this fully-funded project, you will: • develop and employ novel advanced biophysical instrumentation based on optical
-
from both technical and policy perspectives. We have an exciting opportunity for a Postdoctoral Researcher to join the programme. The post holder will be responsible for carrying out research in systems
-
We are looking to recruit two enthusiastic and motivated Postdoctoral Research Assistants to join the group of Professor Ervin Fodor in the Sir William Dunn School of Pathology at the University
-
Department of Medicine. Our overarching aim is to develop better prognostic biomarkers to identify patients at particularly high risk of progression from MDS to sAML. We will build on the “liquid biopsy